Pauline Schneider

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Venues

International journal of molecular sciences

Biomedicines

Leukemia

EJHaem

This page only lists publications with an associated author ORCID identifier.

Publications

Fabienne R S Adriaanse, Pauline Schneider, Susan T C J M Arentsen-Peters, Ana M Neves da Fonseca, Janine Stutterheim, Rob Pieters, C Michel Zwaan, Ronald W Stam
Distinct Responses to Menin Inhibition and Synergy with DOT1L Inhibition in KMT2A -Rearranged Acute Lymphoblastic and Myeloid Leukemia. International journal of molecular sciences 25 (11) (2024)
Fabienne R S Adriaanse, Pauline Schneider, Susan T C J M Arentsen-Peters, Ana M Neves da Fonseca, Janine Stutterheim, Rob Pieters, C Michel Zwaan, Ronald W Stam
Distinct Responses to Menin Inhibition and Synergy with DOT1L Inhibition in KMT2A -Rearranged Acute Lymphoblastic and Myeloid Leukemia. International journal of molecular sciences 25 (11) (2024)
Fabienne R S Adriaanse, Pauline Schneider, Susan T C J M Arentsen-Peters, Ana M Neves da Fonseca, Janine Stutterheim, Rob Pieters, C Michel Zwaan, Ronald W Stam
Distinct Responses to Menin Inhibition and Synergy with DOT1L Inhibition in KMT2A -Rearranged Acute Lymphoblastic and Myeloid Leukemia. International journal of molecular sciences 25 (11) (2024)
Pauline Schneider, Priscilla Wander, Susan T C J M Arentsen-Peters, Kirsten S Vrenken, Dedeke Rockx-Brouwer, Fabienne R S Adriaanse, Veerle Hoeve, Irene Paassen, Jarno Drost, Rob Pieters, Ronald W Stam
CRISPR-Cas9 Library Screening Identifies Novel Molecular Vulnerabilities in KMT2A -Rearranged Acute Lymphoblastic Leukemia. International journal of molecular sciences 24 (17) (2023)
Priscilla Wander, Susan T C J M Arentsen-Peters, Kirsten S Vrenken, Sandra Mimoso Pinhanҫos, Bianca Koopmans, M Emmy M Dolman, Luke Jones, Patricia Garrido Castro, Pauline Schneider, Mark Kerstjens, Jan J Molenaar, Rob Pieters, Christian Michel Zwaan, Ronald W Stam
High-Throughput Drug Library Screening in Primary KMT2A -Rearranged Infant ALL Cells Favors the Identification of Drug Candidates That Activate P53 Signaling. Biomedicines 10 (3) (2022)
Mark Kerstjens, Patricia Garrido Castro, Sandra Mimoso Pinhanҫos, Pauline Schneider, Priscilla Wander, Rob Pieters, Ronald W Stam
Irinotecan Induces Disease Remission in Xenograft Mouse Models of Pediatric MLL-Rearranged Acute Lymphoblastic Leukemia. Biomedicines 9 (7) (2021)
Tito Candelli, Pauline Schneider, Patricia Garrido Castro, Luke A Jones, Eduard Bodewes, Dedeke Rockx-Brouwer, Rob Pieters, Frank C P Holstege, Thanasis Margaritis, Ronald W Stam
Identification and characterization of relapse-initiating cells in MLL-rearranged infant ALL by single-cell transcriptomics. Leukemia (2021)
Priscilla Wander, Laurence C Cheung, Sandra S Pinhanҫos, Luke Jones, Mark Kerstjens, Susan T C J M Arentsen-Peters, Sajla Singh, Grace-Alyssa Chua, Patricia Garrido Castro, Pauline Schneider, M Emmy M Dolman, Bianca Koopmans, Jan J Molenaar, Rob Pieters, C Michel Zwaan, Rishi Sury Kotecha, Ronald W Stam
Preclinical efficacy of gemcitabine in MLL-rearranged infant acute lymphoblastic leukemia. Leukemia 34 (11) (2020)
Pauline Schneider, Patricia Garrido Castro, Sandra M Pinhanços, Mark Kerstjens, Eddy H van Roon, Anke H W Essing, M Emmy M Dolman, Jan J Molenaar, Rob Pieters, Ronald W Stam
Decitabine mildly attenuates MLL -rearranged acute lymphoblastic leukemia in vivo, and represents a poor chemo-sensitizer. EJHaem 1 (2) (2020)

Pauline Schneider.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Pauline Schneider